TRANSGENE (EPA:TNG) | WebDisclosure

Basculer en Français

9473	Companies
185423	Keywords
117773	Articles
99292	Press releases

Home
Companies
TRANSGENE

PRESS RELEASE

published on 06/03/2024 at 07:30, 1 year 6 months ago

Transgene – Premier patient inclus dans la partie Phase II de l’étude randomisée de Phase I/II de son actif phare TG4050, un vaccin thérapeutique individualisé évalué dans les cancers de la tête et du cou
Transgene annonce l'inclusion du premier patient dans la partie Phase II de l'étude randomisée de Phase I/II pour son vaccin TG4050 dans les cancers de la tête et du cou. Démarrage de la sélection des patients pour cette étude internationale

Cancer De La Tête Et Du Cou Étude Clinique Transgene Vaccin Thérapeutique Néoantigènes
BRIEF

published on 05/14/2024 at 17:50, 1 year 6 months ago

Transgene annonce une mise à jour positive pour le premier trimestre 2024 et de futures étapes cliniques

Essais Cliniques Mise À Jour Financière Immunothérapie Anticancéreuse Transgene TG4050
BRIEF

published on 05/14/2024 at 17:50, 1 year 6 months ago

Transgene Announces Positive Q1 2024 Update and Future Clinical Milestones

Clinical Trials Financial Update Cancer Immunotherapy Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 1 year 6 months ago

Transgene fait le point sur ses activités et sa situation financière au premier trimestre 2024
Point sur les activités et la situation financière de Transgene au premier trimestre 2024, avec des données prometteuses de Phase I pour TG4050 et des prévisions de nouvelles données cliniques pour TG4001, TG6050 et BT-001

Biotechnologie Santé Financière Immunothérapie Transgene TG4050
PRESS RELEASE

published on 05/14/2024 at 17:45, 1 year 6 months ago

Transgene provides business and financial update for Q1 2024
Transgene provides business and financial update for Q1 2024, including promising Phase I data on TG4050 and upcoming clinical data expectations on TG4001, TG6050, and BT-001 in H2 2024

Clinical Data Q1 2024 Financial Update Transgene TG4050

Accesswire

Published on 12/05/2025 at 02:35, 7 hours 33 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 7 hours 38 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 9 hours 8 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 11 hours 3 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 11 hours 8 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 09:40, 28 minutes ago

Chery Partners with 2025 Asian Youth Para Games, Taking Center Stage in Global Sports with Passion and Aspiration
Published on 12/05/2025 at 09:30, 38 minutes ago

REPLOID Group AG: Exhibitor at the BIOGAS Convention & Trade Fair in Nuremberg, Germany
Published on 12/05/2025 at 09:05, 1 hour 3 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 1 hour 7 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 1 hour 8 minutes ago

SPECTRIS PLC - Removal

Les Echos

Published on 12/05/2025 at 08:45, 1 hour 23 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 1 hour 23 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 1 hour 26 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 53 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 16 hours 8 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE